What is Actemra?

Actemra (tocilizumab) is an immunosuppressive drug. It is used to treat moderate to severe rheumatoid arthritis, a condition where the body’s immune system attacks its own tissue, including joints. In severe cases, it attacks internal organs .Actemra can also be used to treat(PJIA) polyarticular juvenile idiopathic arthritis  and(SJIA) systemic juvenile idiopathic arthritis.

Investigators found “Clear evidence that the risks of heart attacks, strokes, heart failure, and other conditions were as high or higher for Actemra patients than for patients taking some competing drugs” that included warnings.

Complications Linked to Actemra (tocilizumab)

  • Heart Attack
  • Heart Failure
  • Stroke
  • Pancreatitis
  • Lung Disease
  • Other Life Threatening Long Complications
  • Gastrointestinal Perforations (holes and tears)
  • Death
Call To Speak With a Representative    877-920-4111

STAT Investigation on Actemra Risks

Investigators with STAT analyzed over a half million adverse event reports on a variety of rheumatoid arthritis drugs — including over 13,500 reports involving Actemra (tocilizumab) — and found over 1,100 reports of Actrema patients who suffered from death.

Hundreds of those people died of heart failure, stroke, heart failure or other conditions that are not on the label, like pancreatitis, which has a 50% risk of death.

The investigators found “clear evidence that the risks of heart attacks, strokes, heart failure, and other conditions were as high or higher for Actemra patients than for patients taking some competing drugs.”

Actemra competes with other drugs for arthritis, such as Humira, Remicade and Enbrel. These other drugs carry warnings about the risk of heart failure, heart attacks, and strokes — Actemra does not.

The lack of similar warnings on Actemra may suggest it has a lower risk, but in a head-to-head study of Actemra and Enbrel, the rate of stroke and heart failure was actually 1.5-times higher in Actemra patients.

How Can an Actemra Lawsuit Help?

Filing an Actemra Lawsuit could potentially result in compensation for the following:

  • Medical Expenses Resulting from Actemra Related Injuries of  which Roche/Genentech Failed to Warn Doctors and Patients
  • Pain and Suffering Resulting from Actemra Use
  • Compensation for Treatment and Recovery
  • Wage Losses
  • Punitive Damages

Thousands Died While Taking Actemra

Thousands of people died while taking the arthritis drug Actemra (tocilizumab) — but no one told patients. Now experts are warning about heart failure, pancreatitis, and urging caution for patients at risk of heart attack, stroke, or lung disease.